Drug Maker Sued For Allegedly Concealing Drug’s Adverse Phase 2 Trial Results

(September 14, 2021, 2:00 PM EDT) -- MIAMI — An investor sued a clinical-stage biopharmaceutical company and certain of its senior executives in Florida federal court on Sept. 13, alleging that the defendants violated federal securities laws by...
To view the full article, register now.